RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+14.68%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$3.38B
AUM Growth
+$3.38B
(+26%)
Cap. Flow
+$485M
Cap. Flow
% of AUM
14.35%
Top 10 Holdings %
Top 10 Hldgs %
44.12%
Holding
72
New
14
Increased
22
Reduced
16
Closed
3
Top Buys
| 1 |
Vistra
VST
|
$84.6M |
| 2 |
iShares Bitcoin Trust
IBIT
|
$69.7M |
| 3 |
QuidelOrtho
QDEL
|
$68.1M |
| 4 |
Fluor
FLR
|
$46.1M |
| 5 |
Extreme Networks
EXTR
|
$39.8M |
Top Sells
| 1 |
Collegium Pharmaceutical
COLL
|
$35.9M |
| 2 |
GoodRx Holdings
GDRX
|
$26.7M |
| 3 |
Koppers
KOP
|
$24M |
| 4 |
Mr. Cooper
COOP
|
$20.8M |
| 5 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$17.5M |
Sector Composition
| 1 | Healthcare | 47.6% |
| 2 | Technology | 8.46% |
| 3 | Financials | 7.86% |
| 4 | Industrials | 6.07% |
| 5 | Materials | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $249M | 7.37% | 17,669,588 -557,013 | -3% | -$7.86M |
|
2
Viatris
VTRS
$12.3B
| $220M | 6.51% | 18,442,093 +874,201 | +5% | +$10.4M |
|
3
Roivant Sciences
ROIV
$8.15B
| $211M | 6.23% | 20,000,000 +1,000,000 | +5% | +$10.5M |
|
4
Golar LNG
GLNG
$4.48B
| $157M | 4.63% | 6,506,757 | – | – |
|
5
BGC Group
BGC
$4.65B
| $148M | 4.36% | 19,000,000 -1,000,000 | -5% | -$7.77M |
|
|
6
Mr. Cooper
COOP
$12.1B
| $118M | 3.5% | 1,518,773 -267,022 | -15% | -$20.8M |
|
|
7
QuidelOrtho
QDEL
$1.95B
| $115M | 3.4% | 2,400,000 +1,419,937 | +145% | +$68.1M |
|
|
8
Fluor
FLR
$6.63B
| $110M | 3.25% | 2,600,000 +1,089,828 | +72% | +$46.1M |
|
|
9
Vistra
VST
$64.1B
| $84.6M | 2.5% | +1,213,998 | New | +$84.6M |
|
10
Constellium
CSTM
$2.02B
| $80.3M | 2.37% | 3,630,347 +705,909 | +24% | +$15.6M |
|
|
PTVE
11
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $79.4M | 2.35% | 5,541,393 +501,627 | +10% | +$7.18M |
|
12
Mativ Holdings
MATV
$687M
| $75M | 2.22% | 4,000,000 +1,317,600 | +49% | +$24.7M |
|
13
Arcutis Biotherapeutics
ARQT
$1.86B
| $74.4M | 2.2% | 7,510,000 +865,470 | +13% | +$8.58M |
|
14
Heron Therapeutics
HRTX
$207M
| $74M | 2.19% | 26,713,503 | – | – |
|
|
15
Collegium Pharmaceutical
COLL
$1.22B
| $71.2M | 2.1% | 1,834,027 -924,226 | -34% | -$35.9M |
|
16
ReNew
RNW
$2.76B
| $70.3M | 2.08% | 11,711,700 +1,291,700 | +12% | +$7.75M |
|
|
17
iShares Bitcoin Trust
IBIT
$80.7B
| $69.7M | 2.06% | +1,722,497 | New | +$69.7M |
|
18
ANI Pharmaceuticals
ANIP
$2.03B
| $66.3M | 1.96% | 958,533 -166,467 | -15% | -$11.5M |
|
19
Liberty Global Class A
LBTYA
$4B
| $65.1M | 1.92% | 3,845,351 +866,023 | +29% | +$14.7M |
|
20
Dole
DOLE
$1.4B
| $61.3M | 1.81% | 5,141,388 +610,448 | +13% | +$7.28M |
|
21
Stratasys
SSYS
$906M
| $58.7M | 1.73% | 5,050,000 +800,000 | +19% | +$9.3M |
|
22
Amneal Pharmaceuticals
AMRX
$3B
| $57.8M | 1.71% | 9,541,948 +1,541,948 | +19% | +$9.34M |
|
23
NCR Voyix
VYX
$1.82B
| $57.4M | 1.7% | 4,546,081 +954,853 | +27% | +$12.1M |
|
24
Orthofix Medical
OFIX
$592M
| $53.2M | 1.57% | 3,665,000 | – | – |
|
25
Adeia
ADEA
$1.64B
| $50.7M | 1.5% | 4,640,009 | – | – |
|